Inquiry
Form loading...

Hongjitang Pharmaceutical (Shanghe) Manufacturing l-muscone da muscone

22-04-2024

Tun daga lokacin da aka kafa ta a shekarar 1907, Hongjitang Magunguna sun kasance shaida, magaji, kuma mai haɓaka masana'antar maganin gargajiya ta ƙasar Sin (TCM), suna ɗaukar manufar tarihi ta inganta, ƙarfafawa, da faɗaɗa masana'antar TCM.

Aikin Shanghe na Magunguna na Hongjitang ya ɗauki "Bincike da Masana'antu na Musk na wucin gadi", wanda ya lashe kyautar farko a kyautar ci gaban kimiyya da fasaha ta ƙasa, a matsayin abin da ke haifar da ci gaban kamfanoni.

Aikin Sabunta Masana'antar Magunguna ta Hongjitang (Shanghe) Ana Sa Ran Za A Kammala A Ƙarshen 2024 (1)ikx

Manufarta ita ce ƙirƙirar masana'antar hasumiyar haske ta yanki mai kirkire-kirkire, wadda ke kafa sabon ma'auni. Musk, wanda aka jera a matsayin wani abu mafi kyau a cikin "Shennong Ben Cao Jing," yana fuskantar ƙarancin abinci saboda farautar barewa ta musk ba tare da tsari ba tsawon shekaru.

Ana sa ran kammala aikin sabunta masana'antar harhada magunguna ta Hongjitang (Shanghe) a ƙarshen shekarar 2024 (6)rhr

Bayan da gwamnati ta sanya musk a matsayin dabbar daji mai kariya daga maɓalli a matakin farko, musk ya zama ƙarami, wanda hakan ya sa yake da wahala a ƙirƙiro magungunan mallakar fasaha na ƙasar Sin masu daraja.

A shekarun 1970, ƙasar ta gano binciken da aka yi kan maye gurbin miski na halitta a matsayin muhimmin abin da aka mayar da hankali a kai kuma aka cimma nasarar cimma hakan. "Bincike da Masana'antu na Aikin Musk na Artificial Musk, wanda Hongjitang Pharmaceutical ya shiga, ya sami kyautar farko a cikin Kyautar Ci gaban Kimiyya da Fasaha ta Ƙasa a 2015."

Nasarar ci gaban musk na wucin gadi da l-muscone ya ba da damar ci gaba da amfani da dabarun maganin gargajiya na kasar Sin. An amince da musk na wucin gadi a matsayin sabon magani na Aji na I, wanda ya cike gibin da ke cikin gida kuma ya fara maye gurbin kayan maganin daji na kasar Sin masu tsada da ba kasafai ake samu ba.

Ana sa ran kammala aikin sabunta masana'antar harhada magunguna ta Hongjitang (Shanghe) a ƙarshen shekarar 2024 (10)sfn

Wannan ci gaban ya ceci wani rukunin taskokin ƙasa, magungunan mallakar ƙasar Sin waɗanda ke da wahalar ƙirƙirowa saboda ƙarancin musk na halitta.

Ana sa ran kammala aikin sabunta masana'antar harhada magunguna ta Hongjitang (Shanghe) a ƙarshen shekarar 2024 (3)5jy

A halin yanzu, aikin Hongjitang Pharmaceutical Shanghe yana cikin gagarumin aiki. Da zarar an kammala aikin, ana sa ran zai cimma darajar fitar da kayayyaki ta Yuan biliyan 1.3 a kowace shekara. Yana da nufin cimma aikin sarrafa kansa, dijital, da kuma basira, ta hanyar gina wurin shakatawa ga intanet na masana'antu na 5G+ da kuma masana'antar sinadarai masu kyau ta muhalli.